DrugPatentWatch Database Preview
Details for Patent: 7,368,102
» See Plans and Pricing
Which drugs does patent 7,368,102 protect, and when does it expire?
Patent 7,368,102 protects TOBI PODHALER and is included in one NDA.
This patent has eighteen patent family members in fourteen countries.
Summary for Patent: 7,368,102
| Title: | Pulmonary delivery of aminoglycosides |
| Abstract: | The present invention is directed to the administration of aminoglycosides. In particular, the present invention is directed to compositions and methods for the pulmonary administration of aminoglycosides. According to a preferred embodiment, compositions and methods are provided for the localized treatment of respiratory infections. |
| Inventor(s): | Tarara; Thomas E. (Burlingame, CA), Weers; Jeffry G. (Half Moon Bay, CA), Venthoye; Geraldine (Foster City, CA) |
| Assignee: | Nektar Therapeutics (San Carlos, CA) |
| Application Number: | 10/327,510 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; Dosage form; Delivery; Use; Device; |
Drugs Protected by US Patent 7,368,102
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Speciality Lp | TOBI PODHALER | tobramycin | POWDER;INHALATION | 201688-001 | Mar 22, 2013 | RX | Yes | Yes | Start Trial | Start Trial | Y | TREATMENT OF CYSTIC FIBROSIS PATIENTS WITH PSEUDOMONAS AERUGINOSA | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 7,368,102
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 508735 | Start Trial | |||
| Australia | 2002361897 | Start Trial | |||
| Canada | 2468958 | Start Trial | |||
| Cyprus | 1112560 | Start Trial | |||
| Denmark | 1458360 | Start Trial | |||
| European Patent Office | 1458360 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
